Effect of Peritoneal Lavage With Clindamycin-gentamicin on Laparoscopic Sleeve Gastrectomy

• Status: Completed
• Trial end date: 2015-06-01
• Target enrollment: 0
• Participant gender: All

Summary

A prospective, randomized study will be performed in patients undergoing laparoscopic sleeve gastrectomy (LSG) as bariatric procedure. The patients will be randomized into 2 groups: those patients undergoing an intra-abdominal lavage with normal saline (Group 1) and those undergoing an intra-abdominal lavage with a gentamicin-clindamycin solution (Group 2). Postoperative pain and C reactive protein will be investigated 24 hours after surgery.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hospital General Universitario Elche
• Treatments: Clindamycin; Clindamycin palmitate; Clindamycin phosphate; Gentamicins; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• Body mass index (BMI) >40 Kg/m2

• BMI > 35 Kg/m2 with the presence of comorbidities associated to obesity

• Patients undergoing laparoscopic sleeve gastrectomy (LSG) as bariatric procedure.

Exclusion Criteria:

• Gastroesophageal reflux

• Preoperative diagnosis of chronic renal failure

• Uncontrolled psychiatric disorders

• Active infections

• Malignancies

• Any other concomitant pathology considered as a contraindication for bariatric surgery.